Similarly, B-ALL cells treated with a small molecule Plk1 inhibitor, volasertib (BI6727), showed an induction of pH3 and pH2AX, however, together with a slight accumulation of the Plk1 protein. This evidence concerns the gene PLK1 and acute lymphoblastic leukemia.